The silent players: Atypical BCR?ABL isoforms as biomarkers and therapeutic hurdles in CML pathogenesis (Review). Zhou X, Li A, Kong D, Shi Y, et al. Oncol Rep 2025;54:162.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou X, Li A, Kong D, Shi Y, et al. The silent players: Atypical BCR?ABL isoforms as biomarkers and therapeutic hurdles in CML pathogenesis (Review). Oncol Rep 2025;54:162.
PMID: 40999990